SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-09-000012
Filing Date
2009-03-11
Accepted
2009-03-11 11:52:53
Documents
8
Period of Report
2009-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 13087
2 exhibit99.htm EX-99 40124
3 GRAPHIC img1.gif GRAPHIC 6513
4 GRAPHIC img2.gif GRAPHIC 9338
5 GRAPHIC img3.gif GRAPHIC 14088
6 GRAPHIC img4.gif GRAPHIC 16383
7 GRAPHIC img5.jpg GRAPHIC 1920
8 GRAPHIC img6.jpg GRAPHIC 4605
  Complete submission text file 0001367644-09-000012.txt   128332
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 09671697
SIC: 2834 Pharmaceutical Preparations